Kario, Kazuomi
Ohbayashi, Hiroyuki
Ishii, Hajime
Kato, Mitsutoshi
Nozaki, Minoru
Abiru, Norio
Fukui, Toshiki
Nomura, Kazushi
Fukushima, Yasushi
Itabashi, Naoki
Uchiyama, Kazuaki
Nishizawa, Masafumi
Hata, Yoshiki
Nakamura, Noriko
Kodono, Satoshi
Hirano, Kunio
Katsuya, Tomohiro
Shimosawa, Tatsuo
Shiosakai, Kazuhito
Kato, Go
Taguchi, Takashi
Ohishi, Mitsuru
,
Article History
Received: 6 February 2026
Revised: 16 March 2026
Accepted: 26 March 2026
First Online: 24 April 2026
Compliance with ethical standards
:
: Kazuomi Kario received honoraria from Daiichi Sankyo Co., Ltd. Hiroyuki Ohbayashi received research funding from Kracie, Ltd. and KYORIN Pharmaceutical Co., Ltd. Tomohiro Katsuya received honoraria from Daiichi Sankyo Co., Ltd., Novartis Pharma K.K., Otsuka Pharmaceutical Co., Ltd., and CureApp, Inc. Tatsuo Shimosawa received research funding from SFM Co. Ltd.; consulting fees from Sekisui Medical Co., Ltd. and EP Mediate Co., Ltd.; and honoraria from Daiichi Sankyo Co., Ltd., Novartis Pharma K.K., and Otsuka Pharmaceutical Co., Ltd. Kazuhito Shiosakai, Go Kato, and Takashi Taguchi are employees of Daiichi Sankyo Co., Ltd. Mitsuru Ohishi received honoraria from Daiichi Sankyo Co., Ltd. Hajime Ishii, Mitsutoshi Kato, Minoru Nozaki, Norio Abiru, Toshiki Fukui, Kazushi Nomura, Yasushi Fukushima, Naoki Itabashi, Kazuaki Uchiyama, Masafumi Nishizawa, Yoshiki Hata, Noriko Nakamura, Satoshi Kodono, Kunio Hirano had no conflicts of interest to declare.